The Emerging Biotech Leader
Biotech—it's complicated.A successful product launch requires grit, determination, and clear direction.But let’s be real, the path to launch isn’t a straight one.There are curves, hard turns, and dead ends.Here’s the good news, you don’t have to navigate the complexities…
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 10, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 9, 2026
Latest episodes
From Academia to Biotech: Making the Transition into Biotech Leadership (opens the original)
Read excerpt
Mattia Calissano, VP Medical at SSI Strategy, discusses moving from academic research into drug development, communicating scientific evidence to investors, and adapting to the commercial realities of biotech.
When the Science Becomes a Company (opens the original)
Read excerpt
Samir Ounzain, Scientific Co-Founder and CEO of HAYA Therapeutics, looks at how the founder's role changes as the science becomes a company and the team grows around it.
Flexible Leadership in Biotech: Building Teams Around Program Needs (opens the original)
Read excerpt
Chris Kennedy, CEO of Pacific Genetech, examines a different approach to building leadership teams in early-stage biotech: building organizations around program needs rather than fixed leadership structures.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.